Sk Bioscience competitive analysis

Explore patent oppositions filed by Sk Bioscience against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026
Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein ConjugatesMERCK SHARP & DOHMEMar 18, 2025
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZERJul 11, 2024
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 9, 2021
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHOct 2, 2019
Pneumococcal Polysaccharide Conjugate VaccineGLAXOSMITHKLINE BIOLOGICALS SAAug 6, 2019

Explore Sk Bioscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 12, 2020Polyvalent Pneumococcal Polysaccharide-Protein Conjugate Composition1

Latest PTAB cases involving Sk Bioscience

Discover the latest PTAB cases involving Sk Bioscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sk Bioscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SK BIOSCIENCE61 - -
GLAXOSMITHKLINE BIOLOGICALS SA2910429
MERCK SHARP & DOHME2657615
PFIZER761134412